GRISEOFULVIN, MICROSIZE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for griseofulvin, microsize and what is the scope of freedom to operate?
Griseofulvin, microsize
is the generic ingredient in three branded drugs marketed by Valeant Luxembourg, Actavis Mid Atlantic, Chartwell Rx, Cipla, Cosette, Sandoz, and Sigmapharm Labs Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.Seven suppliers are listed for this compound.
Summary for GRISEOFULVIN, MICROSIZE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 7 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 7,529 |
DailyMed Link: | GRISEOFULVIN, MICROSIZE at DailyMed |
Pharmacology for GRISEOFULVIN, MICROSIZE
Drug Class | Tubulin Inhibiting Agent |
Physiological Effect | Decreased Mitosis Microtubule Inhibition |
Anatomical Therapeutic Chemical (ATC) Classes for GRISEOFULVIN, MICROSIZE
US Patents and Regulatory Information for GRISEOFULVIN, MICROSIZE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | GRISEOFULVIN | griseofulvin, microsize | SUSPENSION;ORAL | 065438-001 | Oct 8, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microsize | SUSPENSION;ORAL | 062483-001 | Jan 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microsize | TABLET;ORAL | 062279-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | GRISEOFULVIN | griseofulvin, microsize | TABLET;ORAL | 091592-001 | Aug 7, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | GRISEOFULVIN | griseofulvin, microsize | SUSPENSION;ORAL | 065200-001 | Mar 2, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.